Stock NOVN NOVARTIS AG
Add to a list

ETFs Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Real-time Estimate Cboe Europe
Other stock markets
 06:13:16 2025-12-08 EST 		5-day change 1st Jan Change
107.58 CHF +0.47% Intraday chart for Novartis AG +3.09% +21.17%
02:29am AlphaValue/Baader Europe Ups Novartis Price Target on 'Strong' Execution, 'Vigorous' Growth MT
02:01am NOVARTIS AG : Upgraded to Buy by JP Morgan ZD

ETFs positioned on Novartis AG

Name Weight AuM Varia. Jan 1. Investor
LYXOR DJ SWITZERLAND TITANS 30 (DR) UCITS ETF- CHF ETF Lyxor DJ Switzerland Titans 30 (DR) UCITS ETF- CHF
10.4% 121 M€ -.--% -
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY ETF Nomura NEXT FUNDS International Equity MSCI-KOKUSAI (Yen-Hedged) ETF - JPY
5.57% 26 M€ +11.85% -
UBS (IRL) ETF PLC MSCI EUROPE ESG UNIVERSAL LOW CARBON SELECT UCITS ETF - ACC - EUR ETF UBS (Irl) ETF plc MSCI Europe ESG Universal Low Carbon Select UCITS ETF - Acc - EUR
2.55% 0 M€ -.--% -
FRANKLIN LIBERTYQ EUROPEAN EQUITY UCITS ETF - EUR ETF Franklin LibertyQ European Equity UCITS ETF - EUR
2% 0 M€ -.--% -
HANETF SATURNA SUSTAINABLE ESG EQUITY HANZERO UCITS ETF - USD ETF HANetf Saturna Sustainable ESG Equity HANzero UCITS ETF - USD
1.87% 0 M€ -.--% -
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD ETF Day Hagan/Ned Davis Research Smart Sector International ETF - USD
1.5% 32 M€ +25.08% -
INDEXIQ FACTORS SUSTAINABLE EUROPE EQUITY UCITS ETF - EUR ETF IndexIQ Factors Sustainable Europe Equity UCITS ETF - EUR
1.41% 154 M€ +17.86% -
FLEXSHARES DEVELOPED MARKETS LOW VOLATILITY CLIMATE ESG UCITS ETF - USD ETF FlexShares Developed Markets Low Volatility Climate ESG UCITS ETF - USD
1.11% 0 M€ -.--% -
HARTFORD MULTIFACTOR DIVERSIFIED INTERNATIONAL ETF - USD ETF Hartford Multifactor Diversified International ETF - USD
0.97% 18 M€ -0.11% -
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF ETF Vanguard International Equity Index Funds - Vanguard FTSE All-World ex-US ETF
0.8% 33,076 M€ +20.06% -
HARTFORD MULTIFACTOR DEVELOPED MARKETS (EX-US) ETF - USD ETF Hartford Multifactor Developed Markets (ex-US) ETF - USD
0.74% 1,096 M€ +28.68% -
AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD ETF AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD
0.53% 0 M€ -.--% -
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB - UCITS ETF DR (C) - USD ETF AMUNDI MSCI WORLD CLIMATE TRANSITION CTB - UCITS ETF DR (C) - USD
0.51% 0 M€ -.--% -
LYXOR MSCI WORLD CLIMATE CHANGE (DR) UCITS ETF - ACC - USD ETF Lyxor MSCI World Climate Change (DR) UCITS ETF - Acc - USD
0.5% 0 M€ -.--% -
123

Company Profile

Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (29.3%); - immunology (18.5%); - cardiovascular, renal and metabolic diseases (17%); - neuroscience (9.4%). The remaining net sales (25.8%) are from contract manufacturing of pharmaceutical products. At the end of 2024, Novartis AG had over 30 production sites worldwide. Net sales are distributed geographically as follows: Europe (30.9%), the United States (42%), Asia/Africa/Australasia (20%), Canada and Latin America (7.1%).
Employees
75,883
Sector
Pharmaceuticals
Calendar
2025-12-07 - American Society of Hematology Meeting - Abstract No - #3198
More about the company

Income Statement and Estimates

More financial data

Ratings

Trader

Trader

This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Investor

Investor

This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Global

Global

This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quality

Quality

This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

ESG MSCI
AAA
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
132.98USD
Average target price
131.65USD
Spread / Average Target
-1.00%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NOVN Stock
  4. ETFs Novartis AG

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition